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Mesenchymal stem cells attenuate angiotensin
II-induced aortic aneurysm growth in
apolipoprotein E-deficient mice
Ryotaro Hashizume, MD,a,b Aika Yamawaki-Ogata MS,a Yuichi Ueda, MD, PhD,a
William R. Wagner, PhD,b and Yuji Narita, MD, PhD,a Nagoya, Japan; and Pittsburgh, Pa
Objective:Aortic aneurysm (AA) is associated with loss of elastin and structural integrity, accompanied by increasedmatrix
metalloproteinase (MMP) expression. These processes are supported by inflammatory macrophages, with mediators such
as tumor necrosis factor- (TNF-). Mesenchymal stem cells (MSCs) contribute to aortic remodeling. Therefore, to
clarify whether MSCs might be useful for AA cell therapy, we examined the effect of MSCs on vascular smooth muscle
cells (SMCs) and macrophages in vitro, on aortic tissue ex vivo, and on aorta in vivo.
Methods: Murine macrophages and SMCs were cultured, with or without bone marrow-derived murine MSCs, for 96
hours in vitro. Gene expression of MMPs and TNF- from macrophages and that of elastin from SMCs were measured.
The murine aortic tissues were cultured with or without MSCs for up to 14 days, followed by measurement of MMP
enzyme activity and elastin content. The in vivo aneurysm model used apolipoprotein E-deficient (apoE/) male mice
receiving angiotensin II (Ang II) infusion for 28 days. MSCs were implanted by laparotomy to the abdominal aortic
adventitial surface from the superior mesenteric artery origin to the left renal artery. Age-matched apoE/mice with or
without Ang II infusion were used for control groups. At the end point, aortic diameter, elastin content, MMPs’ activity,
and cytokines expressed, including interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1), TNF-, insulin-like
growth factor-1 (IGF-1), and tissue inhibitor of metalloproteinases-1 (TIMP-1) were quantified.
Results:MSCs suppressedMMP-2with orwithoutMSCs (2.59 vs 3.94,P< .05),MMP-9 (5.83 vs 9.70,P< .05), andTNF-
(2.79 vs 3.38, P< .05) expression inmacrophages, and promoted elastin expression in SMCs (19.35 vs 3.23,P< .05) in vitro.
MSCs also decreased active MMP-2 activity (0.310 vs 0.0609 U/L, P < .05) and preserved elastin content (68.05 vs 40.29
g/mg, P< .05) ex vivo. AA development was site-specifically inhibited (0.73 vs 1.04 mm aortic diameter, P< .05) and elastin
content was preserved (46.9 vs 25.6g/mg, P< .05) at 4 weeks. Downregulation ofMMPs and IL-6,MCP-1, and TNF-, and
upregulation of IGF-1 and TIMP-1 were demonstrated withMSC implantation in vivo.
Conclusions: MSC implantation inhibits Ang II–induced AA development in apoE/ mice through elastin preservation in the
aortic wall and is associated with attenuated levels of MMPs and inflammatory cytokines. (J Vasc Surg 2011;54:1743-52.)
Clinical Relevance: Aortic aneurysm (AA) rupture is a leading cause of sudden death. Current treatment options are
conventional replacement surgery with a prosthetic conduit or endovascular stent grafting. Procedures on patients diagnosed
with AA, particularly for those with thoracic lesions, are relatively invasive and often occur in an elderly, high-risk population.
Although several pharmacologic strategies have been proposed, mesenchymal stem cell therapy has not been considered as a
therapeutic approach forAA treatment. This report evaluates the efficacy of bonemarrow-derivedmesenchymal stem cells in anAA
animal model in attenuation of aneurysmal growth by immunosuppression and elastin preservation.
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doi:10.1016/j.jvs.2011.06.109The basic phenomena in the pathogenesis of aortic
neurysms (AAs) are degradation of extracellular matrix
ECM) components with increased matrix metalloprotei-
ases (MMPs) and loss of structural integrity of the aortic
all.1 Elastin is the most abundant extracellular protein in
he aortic wall,2 and a lower elastin/collagen ratio is the
ost significant finding in abdominal AA (AAA).3 These
athologic changes are associated with chronic inflamma-
ion of aortic walls, where resident vascular smooth muscle
ells (SMCs) and infiltrating macrophages release MMPs,
articularly MMP-2 and MMP-9.4-6
Bone marrow-derived mesenchymal stem cells (MSCs)
ccount for a small population of cells within the bone
arrow and serve as a nonhematopoietic component with
he capacity to differentiate into a variety of cell lineages.7
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December 20111744 Hashizume et alThese cells can be easily isolated from bone marrow and
expanded in culture.8 MSCs possess the ability to accumu-
late at the site of tissue/organ damage and inflammation.9
They exert a powerful immunosuppressive effect, at least in
part through suppressing T-cell activity and proliferation10
and promoting macrophage polarization into the M2 phe-
notype.11 MSCs have also been reported to upregulate
elastin and downregulate collagen gene expressions in fi-
broblasts12 and are known to participate in remodeling
associated with vascular injury in a variety of settings.13
Given their unique tissue regeneration properties and im-
munosuppressive properties, we hypothesized that MSCs
would be an effective source for AA cell therapy.
To verify this hypothesis we evaluated (1) the effects of
MSCs on SMCs and macrophages in MMP, cytokine, and
elastin gene expression in vitro, (2) the effects of MSCs on
elastin preservation and MMP activity in an ex vivo aortic
culture, and (3) the suppressive action of MSC implanta-
tion on experimental angiotensin II (Ang II)-induced an-
eurysm formation in apolipoprotein E-deficient (apoE/)
mice. Ang II induces aneurysms by an activation of an
inflammatory response associated with medial macrophage
accumulation and the stimulation of a proteolytic cascade
leading to elastin degradation, without any alteration on
arterial blood pressure.14
MATERIALS AND METHODS
This investigation conformed to the Guide for the Care
Fig 1. Gene expression from macrophages and smooth
(MSCs). A, Gene expression of matrix metalloproteinas
frommacrophage decreased withMSC coculture (n 5-6
was not changed in time.D,Elastin expression at 48 and 9
.05 compared with monoculture group. Data are mean
3-phosphate dehydrogenase.and Use of Laboratory Animals (US National Institutes of fealth) and was also approved by the Institute for Labora-
ory Animal Research at the Nagoya University Graduate
chool of Medicine (protocol No. 22133).
Mice. Murine MSCs for in vitro and ex vivo studies,
MCs for in vitro study, and aortic tissue for ex vivo
valuation were isolated from 10 C57BL/6J 4-week-old
ale mice (Japan SLC, Hamamatsu, Japan). Ang II-
nfused AAmodels14 were used to assess the effect of MSCs
n AA development in vivo in apoE/ 24- to 28-week-
ld male mice (C57BL/6 genetic background, Jackson
aboratory, Bar Harbor, Me). The apoE/ mice were
lso used for isolation of MSCs for in vivo cell implantation
tudies.
Methodology. In the Supplementary Materials and
ethods (online only), methodology is provided for the
1) isolation, culture expansion, and differentiation of
SCs, (2) isolation and culture expansion of SMC and
acrophages, (3) coculture model in vitro and ex vivo with
SCs, (4) reverse-transcription polymerase chain reaction
RT-PCR) and quantitative PCR, (5) gelatin zymography
nd histology, and (6) measurement of elastin content and
uantitative protein expression of aortic tissue.
Experimental groups in vivo study. The apoE/
ale mice were divided randomly into four groups: (1) con-
rol (n6)with noAng II infusion orMSC implantation, (2)
ng II infusion without MSC implantation (n 6), (3) Ang
I infusion with MSC implantation (n  7), and (4) Ang II
nfusion with the PKH26-labeled MSC implantation (n 3)
le cells (SMCs) cocultured with mesenchymal stem cells
P)-2, MMP-9, and tumor necrosis factor- (TNF-)
roup).B, andC,Gene expression ofMMPs from SMCs
urs was significantly increased (n 5-9 per group). *P
ndard deviation (error bar). GAPDH, Glyceraldehyde-musc
e (MM
per g
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 staor MSC tracking. Data collected from the first two groups
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Volume 54, Number 6 Hashizume et al 1745were also used for a recently reported drug-delivery study.15
The end point was 28 days for each group.
AAmodel. Male apoE/mice (24 to 28 weeks old),
fed normal chow, were infused with 1000 ng/kg/min Ang
II (Sigma, St. Louis, Mo) for 28 days. Ang II was infused
using Alzet osmotic pumps (DURECT, Cupertino, Calif)
as described previously.16 The osmotic pump implantation
and subsequent laparotomy were performed at the same
time on the animal.
Mice were anesthetized by inhalation of diethyl ether,
followed by an intraperitoneal injection of pentobarbital
(25-50 mg/kg). Pumps were implanted subcutaneously in
the back in the prone position through a small incision that
was closed with suture. The animals were placed supine,
and a long abdominal midline incision from pubis to xi-
phoid was made. The intestines were partially retracted
superiorly out of the abdominal cavity and covered with wet
gauze. The abdominal aorta was exposed from the origin of
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Fig 2. Aortic tissue culture ex vivo with or without m
elastica van Giesen staining revealed focal destruction of t
incubation. In contrast, aorta cocultured withMSCs exhi
Scale bars  50 m. B, A quantitative analysis of elasti
showed no significant differences between the groups in
content and higher gap area in the monoculture compar
.01 compared with monoculture group.C, Elastin conten
the monocultured aorta, it decreased with time (n  5, r
same time point. Data are mean  standard deviation
pro-matrix metalloproteinase (MMP)-2 and active MM
significantly decreased in the coculture group from 3 th
coculture group correspondingly decreased at 7 and
monoculture group at same time point. Data are mean
control data (without MSCs) in C and E, are from Yamasuperior mesenteric artery to the left renal artery. cIn the MSC implantation group (n  7), clumped
SC sheets isolated from apoE/ mice were implanted
nto the retroperitoneal space in front of the exposed aorta
ith forceps. To obtain theMSC sheets,MSCswere cultured
t a concentration of 1  105 cells/well on temperature-
esponsive 6-well plates (CellSeed, Tokyo, Japan) for 7
ays until confluent. MSCs used for cell tracking studies
n  3) were labeled with the fluorescent cell linker
KH26 (Sigma-Aldrich, St. Louis, Mo) before the 7-day
ncubation period.17 The culture temperature was then
ecreased from 37°C to 22°C, and the MSCs detached
pontaneously and floated up as sheets into the culture
edium. Laparotomy and abdominal aortic exposure
nly were performed on control mice (group 2, n  6).
he retracted intestines were returned to the abdominal
avity. The midline abdominal incision was closed with
unning suture layer by layer, and animals were placed
n cages to recover. All incision sites healed without
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th the coculture with MSCs (n  5, respectively). *P 
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bar). D, Representative bands of gel zymography for
are shown. E, Gelatinolytic activity of pro-MMP-2
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December 20111746 Hashizume et alAortic diameter measurements and specimen
preparation. All animals (n  22) were euthanized by
pentobarbital overdosage 28 days after the pump implan-
tation and laparotomy. The aorta from the ascending to the
iliac bifurcation was exposed, and periadventitial tissue was
carefully dissected away from the wall with the assistance of
a dissection stereomicroscope, except for the PKH26-
labeled group. The outer aortic diameters at the level of the
ascending aorta, the abdominal aorta of the phrenic neck,
and the abdominal aorta at the infrarenal proximal neck site
were obtained with a calibrated ocular grid, as described
previously.18
The aorta from the ascending aorta to the iliac bifurca-
tion was then dissected away, and a 2-mm length of aorta at
Fig 3. Mesenchymal stem cell (MSC) implantation attenuates
aneurysmal growth in vivo. A, Representative macroscopic images
of apolipoprotein E-deficient (apoE/), apoE/  angiotensin
II (Ang II), and apoE/  Ang II  MSC aortas. The arrow-
heads indicate typical aneurysm formation in apoE/  Ang II
mice. Scale bar  10 mm. Aortic outer diameter was measured in
all groups at three different positions: (B) ascending, (C) phrenic,
and (D) infrarenal. At the ascending aorta and phrenic level, Ang
II-infusedmice with (n 7) or without (n 6)MSC implantation
had significantly increased aortic diameters compared with
apoE/mice (n 6), whereas at the level of infrarenal aorta, the
diameter of the apoE/  Ang II MSC mice was significantly
lower than that of the apoE/  Ang II mice. Data are mean 
standard deviation. †P  .05 vs apoE/ group. Data for groups
without MSCs are from Yamawaki-Ogata A et al.15 *P  .05 vs
apoE/  Ang II group.the level between the phrenic neck and renal arteries was cut for histology. The remaining aorta was bisected longi-
udinally for elastin quantification, and protein extraction
or zymography and enzyme-linked immunosorbent assay
ELISA).
Statistical analyses. All statistical evaluations were
erformed using Prism 4.0c software (GraphPad Software,
an Diego, Calif), and quantitative values are expressed as
ean standard deviation. The Kolmogorov-Smirnov test
or normality was performed for each data set to determine
he appropriate statistical testing. For the temporal analysis
f SMC or aortic tissue coculture with MSCs, two-way
nalysis of variance (ANOVA) was performed using the
onferroni correction. Analysis of aortic diameter in
poE/ mice or MMP-2 activity was performed using a
ne-way ANOVA with Bonferroni correction. Compari-
ons of macrophage coculture with MSCs were made using
paired t test. Analysis of protein expression in the aortic
all was performed using nonpaired t test or Mann-
hitney analysis, depending on the result of the test for
ormality. All correlation statistics were performed using a
earson correlation method. For all statistical tests, statis-
ical significance was defined at P  .05.
ESULTS
Effects of MSCs on macrophage gene expression.
o investigate the effect of MSCs on macrophage gene
xpression, quantitative PCR was performed for genes ex-
ressing MMP-2, MMP-9, and TNF- after 96 hours of
ncubation. Each measured gene had significantly de-
reased expression in macrophage coculture with MSCs
n  6) compared with macrophage monoculture (n  5;
 .01; Fig 1, A). The multipotency of the MSCs isolated
as demonstrated with supporting data provided in the
upplementary materials (online only).
Effects of MSC on SMC gene expression. To inves-
igate indirect effects of MSCs on SMC gene expression,
uantitative PCRwas performed forMMP-2,MMP-9, and
lastin genes. The quantitative PCR findings demonstrated
o significant differences in MMPs between SMC mon-
cultures for 24 (n 6), 48 (n 6), and 96 (n 8) hours
nd cocultures with MSCs for 24 (n  7), 48 (n  6), and
6 (n  5) hours at any time (Fig 1, B and C), whereas
lastin gene expression showed a significant increase at 48
nd 96 hours (Fig 1, D).
Aortic culture (ex vivo coculture with MSCs).
ortic tissue was cultured ex vivo with or without MSCs,
nd histologic assessment, gelatin zymography for pro-
MP-2 and active MMP-2, and elastin content measure-
ents were performed (n 5 per each group). Under light
icroscopy, elastica van Giesen (EVG) staining revealed
estruction of the medial elastin network in the monocul-
ure group at 14 days’ incubation. In contrast, aorta cocul-
ured with MSCs exhibited improved preservation of the
rchitecture of the medial elastin (Fig 2, A and B). The
lastin content of the cocultured aorta was fairly preserved,
hereas for monocultured aorta, it decreased with time
Fig 2, C). Gelatinolytic activities of pro-MMP-2 signifi-
antly decreased in the coculture group from 3 through 14
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Volume 54, Number 6 Hashizume et al 1747days, likewise active MMP-2 in the coculture group corre-
spondingly decreased from 7 to 14 days (Fig 2, D and E).
Both pro- and active MMP-9 activities were not detectable
by gelatin zymography in this ex vivo study.
Aortic diameter measurement and histology in
vivo. No death or abnormal behavior indicating pain or
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December 20111748 Hashizume et allevels of ascending and phrenic aortas. At the level of
infrarenal aorta, the diameter of the apoE/  Ang II 
MSC group was significantly lower than that of the
apoE/  Ang II group, and no statistical difference
between the apoE/ and apoE/  Ang II  MSC
groups was detected (Fig 3, B and D). In histologic assess-
ment, EVG staining of aortic cross-sections in each group
showed extensive fracturing of the elastic lamellae in
apoE/  Ang II aorta, whereas less fragmented elastic
lamellae were found in apoE/  Ang II MSC aortas,
although the medial elastic fibers of the aorta were evi-
dently denatured to some degree (Fig 4, A-F).
Aortic elastin content measurement in vivo and
protein ELISAs. All retrieved aortic tissue was processed
for elastin content measurement (n  19). The aortic
elastin content in the apoE/  Ang II group (n  6)
decreased significantly compared with the apoE/ group
(n  6), whereas in the apoE/  Ang II MSC group
(n 7), no significant difference was found vs the apoE/
group, and elastin content was significantly greater than for
the apoE/  Ang II group (Fig 4, G). Elastin content
and aortic diameter, when evaluated over both the
apoE/ Ang II and apoE/ Ang IIMSC groups
at the infrarenal level, exhibited an inverse correlation (Fig
4, H). ELISA of explanted aortic tissue demonstrated that
MSC implantation significantly upregulated expression of
insulin-like growth factor-1 (IGF-1) and tissue inhibitor of
metalloproteinases-1 (TIMP-1), and downregulated IL-6,
monocyte chemotactic protein-1 (MCP-1), and TNF-
(n  4-7l, Table).
Zymography of MMPs in vivo. Gelatin zymography
was conducted for all retrieved aortic tissue (n  19). All
MMP activity, including pro-MMP-2, active MMP-2, pro-
MMP-9, and active MMP-9, was significantly decreased in
apoE/  Ang II  MSC aortas compared with
apoE/ Ang II aortas (Fig 5,A-C). Significant positive
correlations were demonstrated between elastin and IGF-1
content (Fig 5, D), and between elastin and TIMP-1 (n 
13 in total, respectively; Fig 5, E) in Ang II infusion groups.
Significant negative correlations between elastin content
and all MMPs tested were also demonstrated (Fig 6, M).
Immunostaining for macrophages and cell tracking
of implanted MSCs in vivo. In the apoE/  Ang II
group, substantial F4/80-positive structures were detected
in the aortic wall that may represent considerable macro-
phage migration. In contrast, apoE/  Ang II MSC
aortas exhibited sparse F4/80-positive structures (Fig 6,
A-F). When PKH26-labeled MSCs were implanted into
apoE/  Ang II mice (n  3) and the tissue was
examined microscopically after 28 days, the labeled MSCs
were readily detectable, indicating that the cells were still
alive but had not proliferated dramatically and had not
penetrated into the aortic wall (Fig 6, G and H). The
implanted MSCs were positive in Sca-1 (Fig 6, I and J) and
CD106 (Fig 6, K and L), indicating maintenance of stem
cell profile after 28 days. cISCUSSION
An AA is a localized dilatation commonly associated
ith arteriosclerosis, and its incidence is on the rise as the
opulation ages.19 Aortic segmental replacement with
rosthetic vessels remains a common therapy, but such
rocedures are highly invasive and involve substantial mor-
idity and mortality, particularly for thoracic aneurysm
rocedures in aged patients. Less invasive stent grafting
pproaches have become dominant for AAA treatment,
ith less acute morbidity, but with endoleak and other risks
hat yield a higher reintervention rate than for open surgical
reatment.20 In AAs, the medial fiber network is impaired,
MC number diminishes, and inflammatory cells invade
he expanding vascular wall. The ECM alteration in the
ortic wall depends on the balance between ECM synthesis
rom vascular SMCs and protease production by SMCs and
nflammatory cells. Although the events that play a role in
neurysm formation and expansion are likely multifactorial,
e believe that the imbalance between them promotes AA
xpansion. Given this background, a strategy to correct the
alance might provide an alternative to current graft re-
lacement therapy.
Elastin degradation in AAs has been reported to be asso-
iated with an infiltration of inflammatory cells and excessive
roduction ofMMPs, both in the clinical field21 and in animal
odels.5 MMPs are a family of zinc-dependent proteinases
hat are present in healthy tissue where they participate in
lastin alteration. They are endogenously regulated by specific
nhibitors, TIMPs.22 Excess matrix elastin degradation that is
ot balanced by elastin elaboration is pivotal in aneurysmal
rowth; therefore, a potential strategy to limit progressive
neurysm growth could include direct inhibition ofMMPs or
romotion of TIMPs, or both. Indeed, several in vivo exper-
ments using an MMP inhibitor have been reported.15,23 A
umber of prospective, randomized clinical trials with doxy-
able. Protein expression in the aortic wall in vivo at 28
ays
ariablea
apoE/  Ang
II
apoE/  Ang
II MSC
(n  4-6)b (n  4-7)
GF-1, ng/mL 5.70  2.63 13.5  4.42c
GF-	1, pg/mL 271.2  144.6 402.7  326.9
IMP-1, pg/mL 1522.8  343.9 2933.2  736.6c
IMP-2, ng/mL 1.10  0.63 1.60  0.95
L-1	, pg/mL 179.9  33.4 374.6  157.2
L-6, pg/mL 3612  979.6 1462  538.0d
CP-1, pg/mL 1374.7  559.5 425.1  179.0d
NF-, pg/mL 53.8  2.80 41.8  6.13d
ng, Angiotensin; apoE, apolipoprotein E; IGF-1, insulin-like growth fac-
or; IL, interleukin; MCP, monocyte chemotactant protein; MSC, mesen-
hymal stem sells; TGF, transforming growth factor; TIMP, tissue inhibitor
f metalloproteinase; TNF, tumor necrosis factor.
Data for the variables are mean  standard deviation.
Control data from Yamawaki-Ogata A et al.15
P  .01, compared with the apoE/  Ang II group.
P  .05.ycline, a nonspecific broad-spectrum MMP inhibitor, have
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cline decreased aneurysmal growth rates as well as inhibited
MMPs in aneurysmal tissue, although this is tempered by the
known adverse effects associated with this agent.
In the present study, MSCs markedly suppressedMMP
gene expression in macrophages in vitro, MMP-2 activity
ex vivo, and MMP activity in vivo, and influenced TIMP-1
in vivo. Negative correlations between elastin content and
MMPs were confirmed. MSCs also decreased expression of
inflammatory cytokines, including IL-6, MCP-1, and
TNF-, which potentially may in turn lead to MMP up-
regulation in the aortic wall. This finding implies thatMSCs
might suppress the excess immunopathologic reactions in
the aneurysmal vascular wall in a paracrine manner without
direct cellular contact. MSCs from bone marrow have been
reported to suppress dendritic cells, T cells, and natural
killer cell activities in vitro, which may be attractive in this
setting.26 Previous work has demonstrated that MSC mobi-
lization and homing are induced by MMP-2, MMP-9,
Fig 5. Matrix metalloproteinases (MMPs) were downre
inhibitor of metalloproteinases-1 (TIMP-1) were upregul
Representative bands of gel zymography for MMPs of
angiotensin II (Ang II) (n  6), and apoE/  Ang I
loaded as a positive control. Activities in (B)MMP-2 and
II  MSC aorta compared with apoE/  Ang II aor
standard deviation. Significant positive correlations were
(E) elastin and TIMP-1 (n  13 in total, respectively) a
MSCs are from Yamawaki-Ogata A et al.15chemokines, or elastases.27,28 MSC are also known to possess lropism for inflammation.9 Because aortic ECM degradation
y MMP-2 and MMP-9, and chronic inflammation of the
ortic wall induced by chemokines, are essential features of
As,MSCs that likelymigrate towardMMPs and chemokines
ave an advantage for aortic aneurysmal cell therapy.
Among the ECM proteins, elastin, which plays an
ntegral role in blood vessel elasticity and is necessary for
yclic distension and contraction, is the most abundant
xtracellular protein in the aortic wall2 and is progres-
ively degraded with aging.29 In an animal model, deg-
adation of the elastin matrix leads to arterial enlarge-
ent, stiffening, and dysfunction, eventually causing
neurysms or blood vessel rupture.30 Excess collagen
laboration in the aortic wall was reported to result in
ccelerated aneurysm formation in apoE/ mice ex-
ressing collagenase-resistant mutant collagen.31 Al-
hough the histopathologic features of AAs are thought
o vary by location (ie, thoracic and abdominal aorta),
lastin degradation is clinically a common feature regard-
ed and insulin-like growth factor-1 (IGF-1) and tissue
ymesenchymal stem cell (MSC) implantation in vivo.A,
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SC (n  7) aortas. B and C, MMPs (0.02 units) were
MMP-9 were significantly decreased in apoE/  Ang
 .05 vs apoE/  Ang II group. Data are mean 
n between (D) elastin and IGF-1 content, and between
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elastin synthesis from SMCs, as well as inhibition of pro-
teases, including MMPs, may be a powerful therapeutic
strategy for AAs. In fact, elastin fiber reconstruction using
adenoviral-mediated expression of tropoelastin reportedly
inhibited aneurysm growth in a rat elastase-infusion
chronic model.33 Our data show that the aortic diameter is
correlated with elastin content in the aortic wall, and elastin
content has positive correlations with IGF-1. We also show
that MSCs markedly influence elastin expression by SMCs in
vitro and play a supporting role toward at least the preserva-
tion of elastin in the aortic wall in ex vivo and in vivo models.
In addition, IGF-1 has been shown to stimulate syn-
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media are hypotrophic.
Third, the murine model is necessarily limited to rela-
tively short investigations, whereas with human disease, the
effect on the remodeling process would need to be deter-
mined over years, not weeks.
Fourth, MSCs are thought to be involved in calcifi-
cation processes within atherosclerotic plaques where
MSCs enter and differentiate into osteogenic cells.38
Although the theory is primarily based on circulating
MSC, long-term evaluation of aortic calcification after
MSC implantation would better define the risk for such
an occurrence in this setting.
In addition, we have not studied another type of cell,
such as MSCs derived from adipocytes or fibroblasts. We
hope to study the effect of other cell types on the experi-
mental AA in the future.
Finally, direct cellular implantation by laparotomy or
thoracotomy with MSCs aspirated from the patient’s bone
marrow may not provide an attractive risk–benefit ratio for
many potential patients. In the future alternative tech-
niques may be established to make such an approach more
attractive, for example, collection of stem cells from autol-
ogous sources other than the bone marrow, such as adipose
tissue or blood. Furthermore, laparoscopic approaches
might be used to deliver the cellular material to the aneu-
rysm adventitial vicinity, or possibly one might envision
methods to deliver MSCs to aortic aneurysmal lesions
intravascularly by endoluminal ultrasound-assisted target-
ing39 or by specific targeting strategies.40
CONCLUSIONS
The presented data clearly indicate that implantation of
MSCs contributes to the attenuation of experimental aneu-
rysmal growth through elastin preservation in the aortic
wall associated with inhibited MMP-2 and MMP-9, and
inflammatory cytokines, including IL-6, MCP-1, and
TNF- in vivo. Evaluation of the observed phenomena at
the cellular, tissue, and animal level collectively point to the
promise of MSC therapy in this setting. Although further
study will be necessary for direct evidence of elastin regen-
eration in the aortic wall, our findings suggest that elastin
synthesis may be induced by local MSC therapy. This new
approachmay offer a therapeutic option to shift the balance
of aneurysm physiology back toward synthetic mechanisms
and away from adverse ECM remodeling.
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